1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. SLEEP APNEA DEVICES MARKET BY PRODUCT TYPE
5.1. Introduction
5.2. Therapeutic Devices
5.2.1. Positive Airway Pressure (PAP) Devices
5.2.2. Oral Appliances
5.2.3. Adaptive Servo-Ventilators
5.2.4. Facial Interfaces/Masks
5.3. Diagnostic Devices
5.3.1. Polysomnography (PSG) Devices
5.3.2. Home Sleep Apnea Testing (HSAT) Devices
5.3.3. Oximeters
5.3.4. Actigraphy Devices
6. SLEEP APNEA DEVICES MARKET BY END-USER
6.1. Introduction
6.2. Hospitals & Sleep Clinics
6.3. Home Care Settings
6.4. Ambulatory Surgical Centers
6.5. Others (Diagnostic Centers, Telemedicine Providers, etc.)
7. SLEEP APNEA DEVICES MARKET BY DISTRIBUTION CHANNEL
7.1. Introduction
7.2. Direct Sales
7.3. Retail Stores
7.4. Online Stores
7.5. Pharmacies
8. SLEEP APNEA DEVICES MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. Japan
8.6.3. India
8.6.4. South Korea
8.6.5. Thailand
8.6.6. Indonesia
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. ResMed Inc.
10.2. Koninklijke Philips N.V.
10.3. Fisher & Paykel Healthcare Limited
10.4. Inspire Medical Systems, Inc.
10.5. BMC Medical Co., Ltd.
10.6. Drive DeVilbiss Healthcare LLC
10.7. Nihon Kohden Corporation
10.8. SomnoMed Limited
10.9. Natus Medical Incorporated
10.10. Compumedics Limited
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES